Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tanapox: first report in a European traveller and identification by PCR.

Literature DB >> 12055809

Tanapox: first report in a European traveller and identification by PCR.

August Stich¹, Hermann Meyer, Bernd Köhler, Klaus Fleischer.

Abstract

Tanapox is a rare pox disease endemic in East Africa. We report the first case of tanapox in a European traveller who contracted the disease in 1999 during a short visit to Tanzania. The diagnosis was made on clinical grounds and confirmed by electron microscopy and a tanapox virus-specific PCR assay.

Entities: Species

Mesh：

Year: 2002 PMID： 12055809 DOI： 10.1016/s0035-9203(02)90295-6

Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN： 0035-9203 Impact factor: 2.184

Keyword Cloud
Cited

12 in total

1. The poxvirus A35 protein is an immunoregulator.

Authors: Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal: J Virol Date: 2010-01 Impact factor: 5.103

2. Orthopox Viruses: Infections in Humans.

Authors: Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal: Transfus Med Hemother Date: 2010-11-17 Impact factor: 3.747

3. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors: Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal: J Virol Date: 2019-09-12 Impact factor: 5.103

4. Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors: Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal: Virology Date: 2009-12-02 Impact factor: 3.616

5. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Authors: Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Mark D Mannie; Rachel L Roper
Journal: Immunology Date: 2009-11 Impact factor: 7.397

Review 10. Emerging viral infections.

Authors: John R Su
Journal: Clin Lab Med Date: 2004-09 Impact factor: 1.935

Tanapox: first report in a European traveller and identification by PCR.

1. The poxvirus A35 protein is an immunoregulator.

2. Orthopox Viruses: Infections in Humans.

3. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

4. Vaccinia virus A35R inhibits MHC class II antigen presentation.

5. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Review 6. Poxviruses and the evolution of host range and virulence.

7. Estimating the geographic distribution of human Tanapox and potential reservoirs using ecological niche modeling.

Review 8. New and emerging infectious diseases.

9. A novel and sensitive real-time PCR system for universal detection of poxviruses.

Review 10. Emerging viral infections.